000 | 01923 a2200529 4500 | ||
---|---|---|---|
005 | 20250515202555.0 | ||
264 | 0 | _c20100617 | |
008 | 201006s 0 0 eng d | ||
022 | _a1950-6007 | ||
024 | 7 |
_a10.1016/j.biopha.2009.08.004 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aXavier, D O | |
245 | 0 | 0 |
_aMetformin inhibits inflammatory angiogenesis in a murine sponge model. _h[electronic resource] |
260 |
_bBiomedicine & pharmacotherapy = Biomedecine & pharmacotherapie _cMar 2010 |
||
300 |
_a220-5 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 |
_aAngiogenesis Inhibitors _xpharmacology |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAnti-Inflammatory Agents _xpharmacology |
650 | 0 | 4 |
_aChemokine CCL2 _xbiosynthesis |
650 | 0 | 4 |
_aChemotaxis, Leukocyte _xdrug effects |
650 | 0 | 4 |
_aCollagen _xbiosynthesis |
650 | 0 | 4 | _aDrug Evaluation, Preclinical |
650 | 0 | 4 |
_aForeign-Body Reaction _xdrug therapy |
650 | 0 | 4 |
_aInflammation _xphysiopathology |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aMetformin _xpharmacology |
650 | 0 | 4 | _aMice |
650 | 0 | 4 |
_aNeovascularization, Pathologic _xprevention & control |
650 | 0 | 4 |
_aPeroxidase _xanalysis |
650 | 0 | 4 | _aSurgical Sponges |
650 | 0 | 4 |
_aTransforming Growth Factor beta1 _xbiosynthesis |
650 | 0 | 4 |
_aTumor Necrosis Factor-alpha _xbiosynthesis |
650 | 0 | 4 |
_aVascular Endothelial Growth Factor A _xbiosynthesis |
700 | 1 | _aAmaral, L S | |
700 | 1 | _aGomes, M A | |
700 | 1 | _aRocha, M A | |
700 | 1 | _aCampos, P R | |
700 | 1 | _aCota, B D C V | |
700 | 1 | _aTafuri, L S A | |
700 | 1 | _aPaiva, A M R | |
700 | 1 | _aSilva, J H | |
700 | 1 | _aAndrade, S P | |
700 | 1 | _aBelo, A V | |
773 | 0 |
_tBiomedicine & pharmacotherapy = Biomedecine & pharmacotherapie _gvol. 64 _gno. 3 _gp. 220-5 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.biopha.2009.08.004 _zAvailable from publisher's website |
999 |
_c19432653 _d19432653 |